Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Gregory Tasian

Achievements

—NIH- and PCORI-Supported Research: His research programme has received ongoing support from major US research funding organizations.
2023Presidential Leadership Award: Received this award from the Societies for Pediatric Urology in recognition of his leadership and development of the PKIDS
—Founder of the PKIDS Care Improvement Network: Established a collaborative network of patients, caregivers, clinicians, and researchers focused on improving outcomes for children with kidney stones.

Dr. Gregory Tasian

Speaker

Children’s Hospital of Philadelphia (CHOP), Philadelphia

About

Dr. Gregory E. Tasian is a pediatric urologist, clinical epidemiologist, and physician-scientist recognized for his research into kidney stone disease in children and adolescents. He practices at Children’s Hospital of Philadelphia (CHOP), where he specializes in the medical and surgical management of pediatric nephrolithiasis. He also serves as a Professor of Surgery and Epidemiology at the University of Pennsylvania’s Perelman School of Medicine.

Dr. Tasian completed his undergraduate studies at Trinity University in Texas, graduating summa cum laude in 2000. He subsequently earned a Master of Science in Neuroscience from the University of Oxford in 2004 and his medical degree from Baylor College of Medicine in 2005. He completed his urology residency at the University of California, San Francisco, followed by fellowship training in pediatric urology at Children’s Hospital of Philadelphia. He later obtained a Master of Science in Clinical Epidemiology from the University of Pennsylvania in 2014.

Children's Hospital of Philadelphia

+1

His clinical work focuses on children with kidney stones, including patients who require surgical intervention, complex diagnostic evaluation, or strategies to prevent recurrence. His research examines why kidney stone disease is becoming more common among younger populations and how environmental, biological, and behavioral factors influence its development.

As a physician-scientist, Dr. Tasian combines clinical trials, large-scale health data analysis, microbiome research, and other analytical approaches to improve the evidence supporting kidney stone prevention and treatment. His work has investigated associations between temperature, heat, humidity, antibiotic exposure, gut microbiome composition, and urinary stone disease. These studies aim to identify potential risk factors and develop more effective prevention strategies.

Dr. Tasian founded the Pediatric KIDney Stone Care Improvement Network, known as PKIDS, which brings together patients, caregivers, clinicians, and researchers to improve care for children with kidney stones. The network supports collaborative research across multiple healthcare institutions, including studies of surgical treatment approaches and patient-centered outcomes.

He also directs CHOP’s Center for Outcomes Research in Surgery and has held research leadership roles in multicenter studies funded by the National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute (PCORI). His research has produced more than 150 peer-reviewed publications, according to his institutional biography.

Achievements and Professional Highlights

  • 2023 Presidential Leadership Award: Received this award from the Societies for Pediatric Urology in recognition of his leadership and development of the PKIDS Care Improvement Network.
  • Founder of the PKIDS Care Improvement Network: Established a collaborative network of patients, caregivers, clinicians, and researchers focused on improving outcomes for children with kidney stones.
  • Research Leadership: Leads clinical and outcomes research at CHOP, including work through the Center for Outcomes Research in Surgery.
  • NIH- and PCORI-Supported Research: His research programme has received ongoing support from major US research funding organizations.
  • Pediatric Kidney Stone Research: Contributed to studies examining the causes, recurrence, prevention, and treatment of kidney stones in children and adolescents.
  • Climate and Kidney Stone Research: Investigated how temperature and humidity relate to kidney stone presentations, contributing to research on environmental influences on human health.
  • Microbiome Research: Contributed to research exploring relationships between gut bacteria, antibiotic exposure, and kidney stone risk.
  • Clinical Trial Development: Participated in multicenter clinical trials designed to improve evidence for kidney stone treatment and prevention.
  • Scientific Publications: Published more than 150 research articles in peer-reviewed journals, according to CHOP.
  • Academic Leadership: Holds a professorship in Surgery and Epidemiology at the University of Pennsylvania and directs research initiatives in pediatric urology.

Education and Qualifications

  • Bachelor’s Degree in Biology and English — Trinity University, Texas, 2000; graduated summa cum laude.
  • Master of Science in Neuroscience — University of Oxford, United Kingdom, 2004.
  • Doctor of Medicine (MD) — Baylor College of Medicine, Houston, Texas, 2005.
  • Urology Residency — University of California, San Francisco.
  • Pediatric Urology Fellowship — Children’s Hospital of Philadelphia.
  • Master of Science in Clinical Epidemiology (MSCE) — University of Pennsylvania, 2014.

Professional Experience

Children’s Hospital of Philadelphia (CHOP), United StatesAttending Pediatric Urologist

Provides specialized medical and surgical care for children and adolescents with kidney stone disease.

Perelman School of Medicine, University of PennsylvaniaProfessor of Surgery and Epidemiology

Conducts academic and clinical research into pediatric urological disease, clinical outcomes, and kidney stone prevention.

Center for Outcomes Research in Surgery (CORES), CHOPDirector

Leads research aimed at improving surgical outcomes through clinical epidemiology, patient-centered research, and data analysis.

Pediatric KIDney Stone Care Improvement Network (PKIDS)Founder and Director

Coordinates collaborative research and quality-improvement efforts focused on pediatric kidney stone care.

Research Interests

  • Pediatric kidney stone disease and nephrolithiasis
  • Kidney stone recurrence and prevention
  • Environmental influences on kidney stone risk
  • Gut microbiome and urinary stone disease
  • Clinical epidemiology and outcomes research
  • Pediatric urological surgery
  • Clinical trials and patient-centered research
  • Health data analytics and evidence-based treatment

Events & Activities

MENA Microbiome Conference 2026: From Biomarkers Discovery to Microbiota-based Therapeutics
Oct 17, 2026
In-Person
Oct 17, 2026
In-Person

MENA Microbiome Conference 2026: From Biomarkers Discovery to Microbiota-based Therapeutics

Free

The MENA Microbiome Conference 2026: From Biomarker Discovery to Microbiota-Based Therapeutics explores emerging research and clinical advances in the human microbiome and its role in health and disease. The conference brings together researchers and healthcare professionals to examine the development of microbiome-based biomarkers, diagnostics, and therapeutic approaches.

Sidra Medicine

  • 2 Days
  • Andaz Hotel – Sahara Ballroom
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education